774 related items for PubMed ID: 34059986
1. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J, Liu P, Hu W, Xu Y, Deng J.
Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
[Abstract] [Full Text] [Related]
2. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
3. Kawasaki disease complicating bilateral facial nerve palsy and giant coronary artery aneurysms: A case report.
Yu X, Liu X, Wang Y, Lu N, Wang M, Sun L.
Medicine (Baltimore); 2019 Feb; 98(7):e14395. PubMed ID: 30762741
[Abstract] [Full Text] [Related]
4. A rare cause of facial nerve palsy in a young infant: Kawasaki disease.
Orgun A, Karagöl C, Pamuk U, Gürsu HA, Çetin İ.
Turk J Pediatr; 2018 Feb; 60(4):433-435. PubMed ID: 30859770
[Abstract] [Full Text] [Related]
5. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
6. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
Wu Y, Wang S, Zhou Y, Yang Y, Li S, Yin W, Ding Y.
PLoS One; 2023 Oct; 18(10):e0292653. PubMed ID: 37824465
[Abstract] [Full Text] [Related]
7. Facial nerve palsy presenting as rare neurological complication of Kawasaki disease: A case report.
Yuan Y, Lu N.
Medicine (Baltimore); 2019 Aug; 98(34):e16888. PubMed ID: 31441865
[Abstract] [Full Text] [Related]
8. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.
Kaohsiung J Med Sci; 2012 Jan; 28(1):23-9. PubMed ID: 22226058
[Abstract] [Full Text] [Related]
9. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
10. Atypical Presentation of Incomplete Kawasaki Disease: A Peripheral Facial Nerve Palsy.
Rodriguez-Gonzalez M, Castellano-Martinez A, Perez-Reviriego AA.
J Emerg Med; 2018 Jul 21; 55(1):118-120. PubMed ID: 29731283
[Abstract] [Full Text] [Related]
11. Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.
Giannouli G, Tzoumaka-Bakoula C, Kopsidas I, Papadogeorgou P, Chrousos GP, Michos A.
Pediatr Cardiol; 2013 Aug 21; 34(6):1476-81. PubMed ID: 23463134
[Abstract] [Full Text] [Related]
12. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
Eur J Pediatr; 2023 Oct 21; 182(10):4399-4406. PubMed ID: 37480545
[Abstract] [Full Text] [Related]
13. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
Cardiovasc Ther; 2021 Oct 21; 2021():6660407. PubMed ID: 34239607
[Abstract] [Full Text] [Related]
14. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED.
Pediatr Cardiol; 2003 Oct 21; 24(2):122-6. PubMed ID: 12457252
[Abstract] [Full Text] [Related]
15. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
Turk J Pediatr; 2020 Oct 21; 62(1):1-9. PubMed ID: 32253860
[Abstract] [Full Text] [Related]
16. Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study.
Türkuçar S, Kaya ÜA, Çakmak F, Haşlak F, Demir F, Karabulut E, Makay B, Bilginer Y, Ayaz NA, Sözeri B, Kasapçopur Ö, Karagöz T, Ünal N, Özen S, Ünsal E.
Turk J Pediatr; 2023 Oct 21; 65(1):64-72. PubMed ID: 36866986
[Abstract] [Full Text] [Related]
17. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
Shuai S, Zhang H, Zhang R, Tang M, Luo E, Yang Y, Gao Y, Yue S, Liang H, Cai J.
J Pediatr (Rio J); 2023 Oct 21; 99(4):406-412. PubMed ID: 36977496
[Abstract] [Full Text] [Related]
18. Outcomes of Kawasaki Disease: A Single-Center Experience.
Uysal F, Bostan OM, Celebi S, Uysal B, Hamitoglu S, Cil E.
Clin Pediatr (Phila); 2015 Jun 21; 54(6):579-84. PubMed ID: 25475592
[Abstract] [Full Text] [Related]
19. Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease.
Ming L, Cao HL, Li Q, Yu G.
Pediatr Cardiol; 2021 Oct 21; 42(7):1496-1503. PubMed ID: 34036412
[Abstract] [Full Text] [Related]
20. Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease.
Masuda H, Ae R, Koshimizu TA, Matsumura M, Kosami K, Hayashida K, Makino N, Matsubara Y, Sasahara T, Nakamura Y.
Clin Rheumatol; 2022 Jan 21; 41(1):137-145. PubMed ID: 34363547
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
